Phase 1 Recurrent Lung Non-Small Cell Carcinoma trials recruiting now

All Recurrent Lung Non-Small Cell Carcinoma trials, every phase

Other phases for Recurrent Lung Non-Small Cell Carcinoma

Phase 1 Recurrent Lung Non-Small Cell Carcinoma trials

• MOv19-BBz CAR T Cells in FRa+ Cancers
  NCT07116057 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
  NCT05234307 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
  NCT05098210 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
  NCT05786924 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 27 locations
• Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
  NCT06616623 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.